Mirum Pharmaceuticals, Inc.
← Back to MIRM Overview

Mirum Pharmaceuticals, Inc. (MIRM)

Solvency & Capital Structure

Total Debt

$323.8M

Net Debt

-$62.5M

Mirum Pharmaceuticals, Inc. currently has $323.8M in total debt. Net debt is -$62.5M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.

Financial Fundamentals

MIRMQuarterly Data • 5Y View

DateTotal Debt ($B)Cash & Inv. ($B)Net Debt ($B)Total AssetsDebt/Assets
2026-03-310.320.39-0.06Net Cash0.8936.3%
2025-12-310.320.38-0.06Net Cash0.8437.9%
2025-09-300.320.38-0.06Net Cash0.7940.6%
2025-06-300.320.300.010.7343.9%
2025-03-310.320.280.040.6945.9%
2024-12-310.320.280.040.6747.4%
2024-09-300.320.280.030.6747.6%
2024-06-300.320.280.040.6647.9%
2024-03-310.310.300.000.6547.2%
2023-12-310.310.290.020.6547.7%
2023-09-300.310.310.000.6547.3%
2023-06-300.310.33-0.02Net Cash0.4469.4%
2023-03-310.000.13-0.13Net Cash0.330.6%
2022-12-310.000.15-0.15Net Cash0.350.6%
2022-09-300.000.19-0.18Net Cash0.360.6%
2022-06-300.000.12-0.12Net Cash0.300.8%
2022-03-310.000.14-0.14Net Cash0.280.9%
2021-12-310.000.16-0.15Net Cash0.290.9%
2021-09-300.000.19-0.19Net Cash0.241.2%
2021-06-300.000.22-0.22Net Cash0.251.2%
2021-03-310.000.21-0.21Net Cash0.221.4%
2020-12-310.000.23-0.23Net Cash0.241.4%
2020-09-300.000.13-0.13Net Cash0.142.4%
2020-06-300.000.15-0.15Net Cash0.162.2%
2020-03-310.000.16-0.16Net Cash0.172.1%
2019-12-310.000.12-0.11Net Cash0.152.5%
2019-09-300.000.13-0.12Net Cash0.160.9%
2019-06-300.000.08-0.08Net Cash0.101.4%
2019-03-310.000.05-0.05Net Cash0.052.5%
2018-12-310.000.05-0.05Net Cash0.050.0%